Cancer-associated Dermatomyositis: Does the PD-1 Checkpoint Pathway Play a Role?

J Rheumatol. 2018 Jun;45(6):731-732. doi: 10.3899/jrheum.180007.

Authors

Moises Labrador-Horrillo¹, Albert Selva-O'Callaghan²

Affiliations

¹ Systemic Autoimmune Diseases Unit, Vall D'Hebron General Hospital, Internal Medicine Department, Universitat Autonoma de Barcelona, Barcelona, Spain. mlabrador@vhebron.net.
² Systemic Autoimmune Diseases Unit, Vall D'Hebron General Hospital, Internal Medicine Department, Universitat Autonoma de Barcelona, Barcelona, Spain.

PMID: 29858454
DOI: 10.3899/jrheum.180007

No abstract available

Publication types

Editorial
Comment

MeSH terms

B7-H1 Antigen
Dermatomyositis*
Humans
Immunotherapy
Neoplasms*
Programmed Cell Death 1 Receptor

Substances

B7-H1 Antigen
Programmed Cell Death 1 Receptor